Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

China · Delayed Price · Currency is CNY

11.34

+0.20 (1.80%)

At close: Apr 15, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Distribution	2.21B	2.30B	2.28B	1.88B	1.74B
Pharmaceutical Distribution Growth	-3.79%	1.11%	21.05%	7.82%	-14.89%
Pharmaceutical Retail	2.69B	1.51B	993.40M	691.07M	586.67M
Pharmaceutical Retail Growth	78.83%	51.53%	43.75%	17.80%	45.98%
Reproductive Hospital	14.41M	12.77M	9.45M	14.77M	4.11M
Reproductive Hospital Growth	12.84%	35.12%	-36.01%	259.30%	105.29%
Drug production revenue	299.84M	75.85M	-	-	-
Drug production revenue Growth	295.32%	-	-	-	-
Unallocated Other Income	-	-	13.50M	6.12M	5.15M
Unallocated Other Income Growth	-	-	120.53%	18.96%	-
Other Income	13.33M	8.43M	-	-	-
Other Income Growth	58.04%	-	-	-	-
Total	5.23B	3.90B	3.29B	2.59B	2.34B
Total Growth	34.07%	18.56%	27.01%	10.79%	-4.61%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	5.23B	3.90B	3.29B	2.59B	2.34B
China Growth	34.07%	18.56%	27.01%	10.79%	-4.75%
Total	5.23B	3.90B	3.29B	2.59B	2.34B
Total Growth	34.07%	18.56%	27.01%	10.79%	-4.75%

Source: S&P Global Market Intelligence.